The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Friday Science Review: February 6, 2009

Two predictive technologies relating to breast cancer:

A team at Centre Hospitalier Universitaire (CHU) Sainte-Justine Research Center in Montreal published a paper in the New England Journal of Medicine in which they report three de novo truncating mutations, in the gene encoding ras GTPase-activating protein SYNGAP1, that appear to cause an autosomal form of nonsyndromic mental retardation.

Plus two non-biotech biology tidbits this week:

  1. if you’re ever in an extra-hot jungle, watch out for the snakes.
  2. there may be something more important about colour that whether you spell it with or without a “u” (one of the principal challenges of cross-border blogging, in case you were wondering).

Bookmark and Share

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


Get every new post delivered to your Inbox.

Join 130 other followers